Top compounds associated with response to LANCL2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Cetuximab	GDSC1000	pan-cancer	AAC	0.09	0.005
mRNA	Cytarabine	GDSC1000	pan-cancer	AAC	-0.097	0.005
mRNA	austocystin d	CTRPv2	pan-cancer	AAC	0.1	0.005
mRNA	GW-2580	GDSC1000	pan-cancer	AAC	0.093	0.006
mRNA	erlotinib:PLX-4032 (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.1	0.006
mRNA	decitabine:carboplatin (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.076	0.007
mRNA	decitabine	CTRPv2	pan-cancer	AAC	0.072	0.007
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.082	0.007
mRNA	selumetinib:decitabine (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.088	0.008
mRNA	CAY10603	GDSC1000	pan-cancer	AAC	-0.077	0.008

Download CSV